Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Sedation During Extubation in Cardiac Surgery
NCT01871129Phase 4Completed
- Sponsor
- Tampere University Hospital
- Start
- Jun 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in hypertension (HTN) (2 arms), sponsored by Tampere University Hospital. Primary endpoint: Highest value of systolic blood pressure during extubation period. Started Jun 2013; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01871129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01871129.